MaxCyte Inc. (MXCT)
NASDAQ: MXCT
· Real-Time Price · USD
1.77
-0.06 (-3.28%)
At close: Oct 16, 2025, 3:59 PM
1.77
0.00%
After-hours: Oct 16, 2025, 07:47 PM EDT
-3.28% (1D)
| Bid | 1.71 |
| Market Cap | 188.69M |
| Revenue (ttm) | 35.75M |
| Net Income (ttm) | -44.77M |
| EPS (ttm) | -0.42 |
| PE Ratio (ttm) | -4.21 |
| Forward PE | -4.12 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.89 |
| Volume | 522,770 |
| Avg. Volume (20D) | 831,953 |
| Open | 1.80 |
| Previous Close | 1.83 |
| Day's Range | 1.75 - 1.86 |
| 52-Week Range | 1.26 - 5.20 |
| Beta | 0.27 |
| Ex-Dividend Date | n/a |
About MXCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MXCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MXCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsMaxCyte Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+10.32%
MaxCyte shares are trading higher after the compan...
Unlock content with
Pro Subscription
2 months ago
-29.9%
MaxCyte shares are trading lower after the company reported worse-than-expected Q2 financial results. Additionally, William Blair downgraded the stock from Outperform to Market Perform.
